|
- IRMS - Nicolae Testemitanu SUMPh
- 1. COLECȚIA INSTITUȚIONALĂ
- MedEspera: International Medical Congress for Students and Young Doctors
- MedEspera 2012
Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12710/20343
Title: | Multidrug resistant tuberculosis |
Authors: | Margineanu, Cătălina Jugaru, Doiniţa Barbu, Elena Juganaru, Victoria |
Issue Date: | 2012 |
Publisher: | State Medical and Pharmaceutical University Nicolae Testemitanu, Medical Students and Residents Association, Scientific Association of Students and Young Doctors |
Citation: | MARGINEANU, Cătălina, JUGARU, Doiniţa, BARBU, Elena, JUGANARU, Victoria. Multidrug resistant tuberculosis. In: MedEspera: the 4th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2012, p. 75. |
Abstract: | Background: In recent years there is an increasing incidence of multidrug resistant tuberculosis
which has important medical, social and economical consequences.
Patients and methods: We report the case of a 44 year old male, smoker which was diagnosed in 2005
with multidrug resistant pulmonary tuberculosis. The patient is from an old disease outbreak, his father
had pulmonary TB.
Results: The patient was hospitalized in 2005 and 2006 with secondary bilateral fibrocaseus ulcerating pulmonary tuberculosis and right pleural tuberculosis with positive BK in sputum culture. He followed and completed the treatment strictly supervised (first-line regimen) and in the second month of
treatment BK was negative. Five months after the treatment ended the patient was hospitalized with reactivated pulmonary TB, miliary form, BK positive in sputum culture. Antibiogram showed the existence
of resistant BK stains at three first-line antituberculosis drugs: Isoniazid, Rifampicin and Streptomycin.
There was established an individualized treatment with four drugs which included reserve drugs. The
treatment lasted 23 months with a smooth evolution of the patient with radiological improvement and
bacteriological negativation.
Conclusions: In severe chronic MDR-TB are important: a correct clinical and laboratory diagnosis,
completed appropriate treatment regimen, monitoring results, patient behavior including his education
regarding the disease. |
metadata.dc.relation.ispartof: | MedEspera: The 4th International Medical Congress for Students and Young Doctors, May 17-19, 2012, Chisinau, Republic of Moldova |
URI: | http://repository.usmf.md/handle/20.500.12710/20343 |
Appears in Collections: | MedEspera 2012
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|